Key Insights

Highlights

Treatment Research

2 treatments under study, led by Pro118 Ophthalmic Solution 0015

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Research Network

Common Treatments

  • Pro118 Ophthalmic Solution 00151
  • Pro118 Ophthalmic Solution 00201

Active Sponsors

  • Laboratorios Sophia S.A de C.V.1

Top Investigators

Related Conditions

  • Seasonal Allergic Conjunctivitis1
  • Conjunctivitis Allergic1
  • Perennial Allergic Conjunctivitis1
  • Ocular Allergy1

Activity Timeline